Key Quantitative Figures
- IPO Date of Allotment: July 30, 2025
- Total Amount Raised: ₹58.80 crore (₹5880 lakhs)
- Breakdown of Raised Amount:
- Issue Related Expenses: ₹7.25 crore
- General Corporate Purpose: ₹8.40 crore
- Capital Expenditure (Capex): ₹43.15 crore
Fund Utilization Status as of September 30, 2026
- Issue Related Expenses: Fully utilized (₹7.25 crore). Note: ₹0.35 crore unutilized amount was transferred to Capex.
- General Corporate Purpose: Fully utilized (₹8.40 crore) for stated purpose.
- Capital Expenditure:
- Balance as on March 31, 2026: ₹36.24 crore (including ₹0.34 crore transferred from Issue Related Expenses)
- Utilized during Q1 FY27: ₹1.45 crore
- Utilized during Q2 FY27: ₹4.32 crore
- Unutilized amount as on September 30, 2026: ₹30.47 crore
- Total Utilization: ₹36.24 crore (opening) + ₹1.45 crore + ₹4.32 crore = ₹42.01 crore utilized against allocated ₹43.15 crore
Current Status of Unutilized Funds
The unutilized Capex amount of ₹30.47 crore is parked in fixed deposits with banks.
Regulatory and Governance Aspects
- Monitoring Agency: Infomerics Valuation and Rating Limited
- Deviation/Variation: Confirmed NO deviation or variation from objects stated in the Prospectus
- Review Process: Statement reviewed by Audit Committee and taken on record by Board of Directors
- Board Meeting Date: November 05, 2025
- Disclosure Date: November 05, 2026
Financial Impact
No financial impact from deviation/variation as none occurred. Funds are being utilized as per original objects stated in the Offer Document. The unutilized Capex funds are earmarked for future capital expenditure purposes as originally intended.